Pharmacological properties of the potent epileptogenic amino acid dysiherbaine, a novel glutamate receptor agonist isolated from the marine sponge Dysidea herbacea
R. Sakai et al., Pharmacological properties of the potent epileptogenic amino acid dysiherbaine, a novel glutamate receptor agonist isolated from the marine sponge Dysidea herbacea, J PHARM EXP, 296(2), 2001, pp. 650-658
Citations number
39
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Dysiherbaine (DH) is a marine sponge-derived amino acid that causes seizure
s upon injection into mice. In this report we investigate the behavioral ef
fects and characterize the pharmacological activity of DH. DH induced convu
lsive behaviors in mice with ED50 values of 13 pmol/mouse, i.c.v. and 0.97
mg/kg, i p. In rat brain synaptic membranes DH displaced binding of [H-3] k
ainic acid (KA) and [H-3] alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropio
nic acid (AMPA) with K-i values of 26 and 153 nM, respectively; in contrast
, DH did not displace the N-methyl-D-aspartic acid (NMDA) receptor ligand [
H-3] CGS-19755. DH displaced [H-3]KA from recombinant GluR5 and GluR6 kaina
te receptor subunits expressed in HEK293 cells with K-i values of 0.74 and
1.2 nM, respectively. In whole-cell voltage-clamp recordings from cultured
rat hippocampal neurons, DH evoked inward currents from both AMPA and KA re
ceptors with EC50 values of 9.7 mM and 210 nM, respectively. AMPA receptor
currents were blocked by GYKI 53655, whereas KA receptor currents were bloc
ked by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). Surprisingly, in calciu
m imaging experiments we found that DH also activated recombinant mGluR5 re
ceptors but did not activate mGluR1 receptors. DH did not activate glutamat
e transporters or gamma -aminobutyric acid A (GABA(A))receptors. These resu
lts indicate that DH is a potent non-NMDAtype agonist with very high affini
ty for KA receptors, as well as a subtype-selective mGluR agonist. DH posse
sses the most potent epileptogenic activity among the amino acids yet ident
ified. This novel excitatory amino acid may prove useful for evaluating the
physiological and pathological roles of non-NMDA receptors, especially KA
receptors, in the central nervous system.